Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells

Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and is characterized by poor clinical outcomes, with the majority of patients not being eligible for curative therapy and treatments only being applicable for early-stage tumors. CD44 is a receptor for hyaluronic acid (HA) and...

Full description

Bibliographic Details
Main Authors: Stefania Cannito, Valeria Bincoletto, Cristian Turato, Patrizia Pontisso, Maria Teresa Scupoli, Giorgia Ailuno, Ilaria Andreana, Barbara Stella, Silvia Arpicco, Claudia Bocca
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Molecules
Subjects:
HCC
CD44
hyaluronic acid
liposomes
macrophages
Online Access:https://www.mdpi.com/1420-3049/27/3/1062

Internet

https://www.mdpi.com/1420-3049/27/3/1062

Similar Items